| Primary |
| Drug Use For Unknown Indication |
15.0% |
| Cystoid Macular Oedema |
14.2% |
| Product Used For Unknown Indication |
10.6% |
| Antiretroviral Therapy |
8.9% |
| Diabetic Retinal Oedema |
7.7% |
| Retinopathy |
6.5% |
| Hiv Infection |
6.1% |
| Macular Oedema |
5.3% |
| Back Pain |
4.9% |
| Rheumatoid Arthritis |
3.3% |
| Skin Test |
2.4% |
| Osteoarthritis |
2.0% |
| Breast Cancer |
1.6% |
| Dermatitis Allergic |
1.6% |
| Eczema |
1.6% |
| Neck Pain |
1.6% |
| Pain |
1.6% |
| Pain In Extremity |
1.6% |
| Rash |
1.6% |
| Steroid Therapy |
1.6% |
|
| Chorioretinal Disorder |
13.6% |
| Visual Acuity Reduced |
10.0% |
| Product Contamination |
8.2% |
| Product Contamination Microbial |
7.3% |
| Drug Ineffective |
6.4% |
| Weight Increased |
6.4% |
| Drug Interaction |
5.5% |
| Retinopathy Proliferative |
4.5% |
| Visual Impairment |
4.5% |
| Skin Discolouration |
3.6% |
| Spinal Cord Infarction |
3.6% |
| Tendon Rupture |
3.6% |
| Vaginal Haemorrhage |
3.6% |
| Articular Calcification |
2.7% |
| Endophthalmitis |
2.7% |
| Extraskeletal Ossification |
2.7% |
| No Adverse Event |
2.7% |
| Optic Atrophy |
2.7% |
| Rash |
2.7% |
| Suicidal Ideation |
2.7% |
|
| Secondary |
| Product Used For Unknown Indication |
34.3% |
| Diabetic Retinal Oedema |
8.9% |
| Hypertension |
8.5% |
| Cystoid Macular Oedema |
7.8% |
| Retinopathy |
7.8% |
| Rheumatoid Arthritis |
6.4% |
| Rash |
3.0% |
| Choroidal Neovascularisation |
2.3% |
| Pain |
2.3% |
| Eczema |
2.1% |
| Psoriasis |
2.1% |
| Asthma |
1.8% |
| Muscle Spasms |
1.8% |
| Nephrotic Syndrome |
1.8% |
| Age-related Macular Degeneration |
1.6% |
| Arthralgia |
1.6% |
| Hiv Infection |
1.6% |
| Iridocyclitis |
1.6% |
| Dermatomyositis |
1.4% |
| Factor Viii Inhibition |
1.4% |
|
| Product Contamination |
21.8% |
| Weight Increased |
9.0% |
| Secondary Adrenocortical Insufficiency |
6.4% |
| Cushingoid |
5.1% |
| Drug Ineffective |
5.1% |
| Rash |
5.1% |
| Cushing's Syndrome |
3.8% |
| Iridocyclitis |
3.8% |
| Macular Oedema |
3.8% |
| Neuropathy Peripheral |
3.8% |
| Posterior Reversible Encephalopathy Syndrome |
3.8% |
| Suicidal Ideation |
3.8% |
| Vaginal Haemorrhage |
3.8% |
| Vestibular Disorder |
3.8% |
| Vomiting |
3.8% |
| Agitation |
2.6% |
| Dizziness |
2.6% |
| Drug Exposure During Pregnancy |
2.6% |
| Erythema |
2.6% |
| Eyelid Ptosis |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
41.4% |
| Drug Use For Unknown Indication |
13.1% |
| Psoriasis |
7.2% |
| Hypertension |
4.5% |
| Acne |
4.2% |
| Pain |
4.0% |
| Rheumatoid Arthritis |
3.7% |
| Depression |
2.0% |
| Hepatitis C |
2.0% |
| Asthma |
1.9% |
| Prophylaxis |
1.9% |
| Anxiety |
1.8% |
| Psoriatic Arthropathy |
1.8% |
| Nausea |
1.7% |
| Eczema |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Diabetes Mellitus |
1.5% |
| Rash |
1.4% |
| Arthritis |
1.3% |
| Arthralgia |
1.3% |
|
| Vomiting |
10.6% |
| Psoriasis |
9.3% |
| Weight Decreased |
8.1% |
| Rash |
6.8% |
| Pneumonia |
6.6% |
| Weight Increased |
5.5% |
| Pain |
5.1% |
| Myocardial Infarction |
4.4% |
| Nausea |
4.2% |
| Pulmonary Embolism |
4.0% |
| Pyrexia |
4.0% |
| Wound Infection |
3.8% |
| Pain In Extremity |
3.6% |
| Wound Infection Staphylococcal |
3.6% |
| Deep Vein Thrombosis |
3.4% |
| Injection Site Pain |
3.4% |
| Swelling |
3.4% |
| Thrombosis |
3.4% |
| Urticaria |
3.4% |
| Vaginal Haemorrhage |
3.4% |
|
| Interacting |
| Product Used For Unknown Indication |
25.9% |
| Hiv Infection |
24.1% |
| Antiretroviral Therapy |
12.1% |
| Arthralgia |
5.2% |
| Back Pain |
5.2% |
| Musculoskeletal Pain |
5.2% |
| Seronegative Arthritis |
5.2% |
| Tendon Rupture |
5.2% |
| Asymptomatic Hiv Infection |
3.4% |
| Compression Fracture |
1.7% |
| Cystoid Macular Oedema |
1.7% |
| Intervertebral Disc Degeneration |
1.7% |
| Limb Injury |
1.7% |
| Pain In Extremity |
1.7% |
|
| Drug Interaction |
50.0% |
| Syncope |
12.5% |
| Vomiting |
12.5% |
| Cushing's Syndrome |
6.3% |
| Lipohypertrophy |
6.3% |
| Sleep Disorder |
6.3% |
| Swelling Face |
6.3% |
|
